Objective:

To develop and validate a rapid, automated point-of-care molecular test for detecting hepatitis C virus (HCV) RNA.

Approach:

Key Findings:

• The DASH® HCV test provides rapid results in about 15 minutes.
• It has a detection limit of 200 IU/mL and can detect HCV genotypes 1 through 6.
• The test showed 100% positive and negative agreement with established RNA assays.

Interpretation:

Rapid molecular POC testing could streamline HCV diagnosis, enabling confirmation of active infection during a single visit, particularly in settings with limited access to centralized labs.

Limitations:

• The assay's analytical sensitivity is lower than high-throughput laboratory tests.
• Further studies are needed to evaluate operational performance in real-world settings.

Conclusion:

The DASH® HCV test has the potential to improve HCV diagnosis and reduce patient loss to follow-up, but its use may be limited for treatment monitoring.

Sources:

• The Journal of Infectious Diseases
Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.